CN Patent

CN102574830A — 取代的1-氰基乙基杂环基甲酰胺化合物750

Assigned to AstraZeneca AB · Expires 2012-07-11 · 14y expired

What this patent protects

本发明提供式(I)的化合物、所述化合物制备方法、含有所述化合物的药物组合物及所述化合物在治疗中的用途，其中y、m、n、R 1 、R 2 和Q如说明书中所定义。

USPTO Abstract

本发明提供式(I)的化合物、所述化合物制备方法、含有所述化合物的药物组合物及所述化合物在治疗中的用途，其中y、m、n、R 1 、R 2 和Q如说明书中所定义。

Drugs covered by this patent

Patent Metadata

Patent number
CN102574830A
Jurisdiction
CN
Classification
—
Expires
2012-07-11
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.